Demaceo Howard, MD
Pain Medicine · Dallas, TXNPI 1225006752
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $30,081 of the $39,185 with a category attached, or 76.8%. AbbVie accounts for 76.8% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $31,673 and has fallen 97.3% since, to $840 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 286 payments — averaging $137.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- Abbott$4K
- Medtronic$3K
- Nevro Corp.$754
- Boston Scientific$498
- Pfizer$195
- plus $1K from 19 others
What the payments were for
- Food & beverage$9,03323%
- Education$720%
- Gifts$30,08177%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $30,081 |
| Abbott | 124 | $3,510 |
| Medtronic(2 entities) | 66 | $3,064 |
| Nevro Corp. | 32 | $754 |
| Boston Scientific | 8 | $498 |
| Pfizer | 10 | $195 |
| Collegium Pharmaceutical, Inc. | 9 | $162 |
| Curonix LLC | 2 | $149 |
| MML US, Inc. | 2 | $130 |
| Scilex Pharmaceuticals Inc. | 7 | $112 |
| Teva Pharmaceuticals USA, Inc. | 1 | $94 |
| Biodelivery Sciences International, Inc. | 7 | $91 |
| Painteq LLC | 1 | $45 |
| Spinal Simplicity, LLC | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| Virtus Pharmaceuticals LLC | 2 | $34 |
| SPR Therapeutics, Inc | 2 | $32 |
| Si-bone, Inc. | 1 | $29 |
| GRT US Holding, Inc. | 1 | $26 |
| Assertio Therapeutics, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Saluda Medical Americas, Inc. | 1 | $17 |
| Avanos Medical | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$30,081
- PROCLAIM$731
- INTELLIS$550
- SYNCHROMED$336
- ADAPTIVESTIM$267
- Proclaim Family of SCS IPGs$180
- INTELLIS ADAPTIVESTIM$178
- INCEPTIV$175
- PENTA$144
- GENERAL PAIN MANAGEMENT$143
- Proclaim IPG$143
- OCTRODE$138
- SPECTRA WAVEWRITER$131
- WaveWriter Alpha Prime 16$120
- Vanta$117
- ReActiv8$102
How this compares
$39,185 in reported general payments places this provider in the 90th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 901 | $27,870 |
| Buprenorphine | 70 | $13,148 |
| Xtampza ErOxycodone Myristate | 23 | $11,045 |
| Hysingla ErHydrocodone Bitartrate | 13 | $8,762 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 235 | $7,892 |
| Pregabalin | 131 | $2,799 |
| Tizanidine Hcl | 182 | $2,490 |
| Gabapentin | 191 | $2,412 |
| Lidocaine | 23 | $2,376 |
| Naloxone Hcl | 35 | $2,087 |
| Cyclobenzaprine Hcl | 155 | $1,652 |
| Methocarbamol | 104 | $1,290 |
| Buprenorphine Hcl | 28 | $1,140 |
| Oxycodone Hcl | 87 | $866 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 69 | $844 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl, Morphine Sulfate | $36 | $14,540113 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $162 | $11,04523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Dallas
- Justin ThompsonDallas$45K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
- Puneet SayalCorpus Christi$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.